Homozygosity for the C 677 →T mutation of 5,10‐methylenetetrahydrofolate reductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Coronary Artery Disease

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00019501-200103000-00001PMID 11281306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular risk factors in the Northern Sweden MONICA Study.

  2009cited by this paper
• Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case–control study from northern Sweden

  1998cited by this paper
• Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

  1998cited by this paper
• The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.

  1997cited by this paper
• Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.

  1997cited by this paper
• A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.

  1997cited by this paper
• A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction.

  1997cited by this paper
• The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

  1997cited by this paper
• Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.

  1997cited by this paper
• Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.

  1997cited by this paper
• Plasma homocysteine levels and mortality in patients with coronary artery disease.

  1997cited by this paper
• Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.

  1997cited by this paper
• Molecular variant of 5,10-methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population.

  1996cited by this paper
• Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

  1996cited by this paper
• Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation.

  1996cited by this paper
• Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation.

  1996cited by this paper
• Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study.

  1996cited by this paper
• A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.

  1996cited by this paper
• Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction.

  1996cited by this paper
• Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.

  1996cited by this paper
• Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.

  1996cited by this paper
• Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease.

  1996cited by this paper
• Plasma homocysteine in the acute and convalescent phases after stroke.

  1995cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.

  1995cited by this paper
• Serum total homocysteine and coronary heart disease.

  1995cited by this paper
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

  1995cited by this paper
• Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.

  1994cited by this paper
• Extraction of high quality genomic DNA from microsamples of human blood.

  1994cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.

  1991cited by this paper
• Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase.

  1988cited by this paper
• Why are diabetes, stomach cancer and circulatory diseases more common in Northern Sweden?

  1986cited by this paper

• Homocysteine levels are associated with diabetes mellitus in Chinese with H-type hypertension

  2024cites this paper
• MTHFR gene polymorphisms and susceptibility to myocardial infarction: Evidence from meta-analysis and trial sequential analysis

  2023cites this paper
• Association between insulin resistance and total plasma homocysteine levels in type 2 diabetes mellitus patients in south west Nigeria.

  2017cites this paper
• C667T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene and susceptibility to myocardial infarction: A systematic review and meta-analysis.

  2016cites this paper
• Role of methylenetetrahydrofolate reductase 677C→T polymorphism in the development of myocardial infarction: evidence from an original study and updated meta-analysis

  2016cites this paper
• Gene polymorphism and some inflammatory biomarkers associated with coronary artery disease in Egyptian Population

  2015cites this paper
• Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score.

  2014cites this paper
• Búsqueda de selección en el polimorfismo 677C>T (c.665C>T) del gen de la metilentetrahidrofolato reductasa (MTHFR) en una población Colombiana

  2014cites this paper
• Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians

  2012cites this paper
• Nutritional Factors, Homocysteine and C677T Polymorphism of the Methylenetetrahydrofolate Reductase Gene in Algerian Subjects with Cardiovascular Disease

  2012cites this paper
• Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials

  2011cites this paper
• Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials

  2011cites this paper
• Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls.

  2011cites this paper
• Hiperhomocisteinemia, polimorfismos genéticos y síndrome coronario agudo

  2011cites this paper
• Association of Methylenetetrahydrofolate Reductase C677T and Cystathionine β-Synthase Polymorphisms in Cardiovascular Disease in the Algerian Population

  2010cites this paper
• Mendelian randomisation and cardiovascular disease

  2009cites this paper
• Study on Homocysteine Levels and Methylenetetrahydrofolate Reductase Gene Variant (C677T) in a Population of Buenos Aires City

  2008cites this paper
• Thrombophilie et infarctus du myocarde

  2007cites this paper
• Effect of Methylenetetrahydrofolate Reductase Gene Mutation on Plasma Homocysteine Level and its Prevalence in Arterial Diseases

  2006cites this paper
• Homocysteine in cardiovascular disease with special reference to longitudinal changes

  2005cites this paper
• The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening

  2004cites this paper
• Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects

  2004influential citation
• Elevated plasma homocysteine: cause or consequence of myocardial infarction?

  2004cites this paper
• Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.

  2003cites this paper
• The Northern Sweden MONICA Project. Bibliography.

  2003cites this paper
• Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort- evaluation of risk factors and their interactions

  2003cites this paper
• MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

  2002cites this paper
• Homocysteine and cardiovascular disease: current evidence and future prospects.

  2002cites this paper
• Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

  2002cites this paper
• Laboratory evaluation of hypercoagulability with venous or arterial thrombosis.

  2002cites this paper
• Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.

  2002cites this paper